Christiane Neumann

77PUBLICATIONS
371CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (77)

|Jun 29, 2026
The evolving role of cytokines for CAR-T cell manufacturing and beyond.

|Jun 22, 2026
Impact of ASO conjugation and receptor binding affinity on intracellular transport of mono- and bispecific TfR- and CD98-BrainshuttleTM variants.

|Jun 19, 2026
First-in-human study of lomvastomig, a PD-1-TIM-3 bispecific antibody, in patients with advanced and/or metastatic solid tumors.

|Jun 12, 2026
Tobemstomig, a Novel Bispecific Antibody, Preferentially Blocks PD-1 and LAG-3 on CD8 TILs to Expand Stem-like T Cells for Sustained Tumor Control.

|Apr 28, 2026
Engineering of acidic pH-responsive anti-CD3 binding antibodies.

|Jan 22, 2026
Molecular features of response and resistance to glofitamab, a T-cell engager for treatment of large B-cell lymphoma.

Stephan Schmeing, Sina Nassiri, Gabrielle Leclercq-Cohen

Pageof 13

Frequent Collaborators

16 joint publications

Pablo Umaña

8 joint publications

Johannes Sam

7 joint publications

Sylvia Herter

7 joint publications

Anne Schoenle